TARIS Biomedical scores $32 mln
TARIS Biomedical, which focuses on developing new treatments for urologic diseases, has secured $32 million in funding.
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Flagship Ventures
Editas Medicine raised $120M for advance genome editing
Editas Medicine, a leading genome editing company, raised $120 million in a highly oversubscribed Series B private financing. It…
New capital $40M for Joule Unlimited
The amount of 40 million dollars was raised recently from Joule Unlimited, a biofuels company. The funding round was led by…
Initial investment $217M at Denali Therapeutics
Having received an initial investment commitment of 217 million dollars, Denali Therapeutics, a new biotechnology company focused…